|
⚲
|
| Keyboard |
| Newcomer Lee Nisley
✚
|
|
|---|---|
| CIK # | 0001788981 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001788981] | |
| 4 | [0001788981] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Coherus Oncology Inc | |
| Newcomer Lee Nisley | |
| Myriad Genetics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 112,000 | $0.00 | |
|
Myriad Genetics Inc MYGN
Common Stock
|
2025-06-05 | Grant | 49,796 | $0.00 | |
|
Myriad Genetics Inc MYGN
Common Stock
|
2024-06-06 | Grant | 15,695 | $0.00 | |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2024-06-03 | Grant | 112,000 | $0.00 | |
|
Myriad Genetics Inc MYGN
Common Stock
|
2024-05-13 | Sell | 6,200 | $25.30 | 156,860 |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2023-06-07 | Grant | 38,250 | $0.00 | |
|
Myriad Genetics Inc MYGN
Common Stock
|
2023-06-01 | Grant | 15,151 | $0.00 | |
|
Myriad Genetics Inc MYGN
Common Stock
|
2022-06-02 | Grant | 17,275 | $0.00 | |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2022-02-02 | Grant | 54,000 | $0.00 | |
|
Myriad Genetics Inc MYGN
Common Stock
|
2021-06-03 | Grant | 12,848 | $0.00 | |
|
Myriad Genetics Inc MYGN
Common Stock
|
2020-12-04 | Grant | 15,889 | $0.00 | |
|
Myriad Genetics Inc MYGN
Common Stock
|
2019-12-05 | Grant | 11,687 | $0.00 |